OncoBone at ENA 2026

Nov 18–20, 2026 Barcelona, Spain ~1.5k attendees Website

OncoBone brings 2 presentations to ENA 2026 in Barcelona. Its posters cover models of cancer that has spread to bone, in animals and outside the body. It tests standard-of-care therapies in bone metastasis models of triple-negative breast cancer, castration-resistant prostate cancer and multiple myeloma bone disease, and introduces an ex vivo bone metastasis culture platform for triple-negative breast cancer.

OrganizationENA 2026 Attendance
CROs & CDMOs
Preclinical contract research company specialising in oncology and bone disease models, including bone metastasis.
Poster
Fri Nov 20
10:45–11:15am
1:30–3pm

Explore the full ENA 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Barcelona. Leave your work email and we’ll be in touch.

Privacy

Download the full ENA 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from OncoBone

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by EORTC, the NCI or the AACR. Submit a correction